Studies Supporting PDTs Often Short on Rigor, Inclusivity, Research Finds

Managed Healthcare Executive November 16, 2023
Peter Wehrwein, Managing Editor

There were some positive findings. But of the 20 FDA-authorized prescription digital therapeutics (PDTs) identified by researchers, only two met all the criteria for high-quality research. The results were published in Health Affairs.

The evidence supporting the safety and efficacy of 20 FDA-authorized prescription digital therapeutics (PDTs) is spotty, with 40% having no clinical studies corresponding with their FDA authorization and only 2 were supported by studies that met the criteria for quality research, according to a study published in this month’s issue of the

Corresponding author Sanket S. Dhruva, M.D., M.H.S, said in an interview with Managed Healthcare Executive that the study’s finding was not that the evidence is uniformly poor. Dhruva and his colleagues found, for example, that...

Today's Sponsors

Today's Sponsor